Sanofi expects 2023 business EPS to grow low single digits at CER, barring unforeseen major adverse events. Applying average January 2023 exchange rates, the currency impact on 2023 business EPS is estimated between -3.5% to -4.5%.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on SNY:
- Sanofi (NASDAQ:SNY) Stock Down on Mixed Q4 Results
- Sanofi price target raised to EUR 100 from EUR 91 at Berenberg
- Sanofi plans to lay off staff at vaccine factories in India, Reuters says
- Regeneron, Sanofi announce EC expansion of Dupixent marketing authorization
- Regeneron, Sanofi announce CHMP opinion recommending EU approval for Dupixent